iiinova — where your digital self keeps evolving

Jyoti Baharani @renalpages.bsky.social · 04/11/2025

🩺 New paper out in The Journal of Vascular Access: “Mapping national variation in #hemodialysis #CVC management: A UK-wide survey.” 🔗 doi.org/10.1177/1129... One of the commonest procedures in renal care — central venous catheter insertion — yet still no national standard for how it’s done.

doi.org

273

Jyoti Baharani @renalpages.bsky.social · 28/10/2025

Our new work in @asaiojournal PD-PREDICT machine learning model to predict survival in patients starting peritoneal dialysis💬 In simple terms: the tool helps patients and clinicians have clearer, more personalised discussions about what to expect when starting #PD. journals.lww.com/asaiojournal...

journals.lww.com

020

Jyoti Baharani @renalpages.bsky.social · 20/09/2025

Over 2 days, our Dialysis Roadshows @uhbTrust welcomed 100+ patients, carers & families. Every attendee gave positive feedback & said they’d recommend to a loved one ❤️. A great blend of clinical expertise & lived experience. Already looking forward to next year! #Dialysis #KidneyCare

181

Reposted by Jyoti Baharani

Indranil Dasgupta @profdg.bsky.social · 04/09/2025

Exciting opportunities- each fellowships is for for 2 years initially and expected to lead to MD or PhD

041

Jyoti Baharani @renalpages.bsky.social · 04/09/2025

🚨 Exciting Fellowships! 🚨 Join UHB NHS FT as a Clinical Research Fellow in Renal Medicine (12m fixed term, £65k, Birmingham). Apply now: 🧠 Dialysis & Cognition: jobs.nhs.uk/candidate/joba… 💉 Hypertension & Dialysis: jobs.nhs.uk/candidate/joba�� #Renal #Research

jobs.nhs.uk

073

Jyoti Baharani @renalpages.bsky.social · 21/08/2025

🚨 Nephrology #ESCE Prep Course 🚨 📅 6–7 Sept 2025 | 💻 Online | 💷 £200 For ST4+ clinicians: core topics, exam technique & case-based learning. 📌 Register: jbameded@gmail.com #Nephrology #SCE #ExamPrep #RenalMedicine

020

Jyoti Baharani @renalpages.bsky.social · 08/08/2025

🧬 Up to 30% of adults with CKD have an inherited form—yet family history is still underused. 10 tips to do this well 🍎 It’s free, powerful & can change the whole pathway. #Nephrology #CKD academic.oup.com/ckj/advance-ar…

294

Jyoti Baharani @renalpages.bsky.social · 02/08/2025

📢 Calling nephrologists in Pakistan, Bangladesh, and Nepal — we're running a short survey on Conservative Kidney Management practices in South Asia. Help shape care for advanced CKD patients - link below 🔗 url.uk.m.mimecastprotect.com/s/kuYVC7DxMS... #Nephrology #CKM #CKD #RenalCare

url.uk.m.mimecastprotect.com

Mimecast TTP Web Portal

002

Jyoti Baharani @renalpages.bsky.social · 25/06/2025

A pleasure to discuss the @theisn.org #SRC centre work between my centre in BIrmingham and @davyip.bsky.social in Mauritius - inspired also by the fab work happening in Africa and motivated to do better 🥰

041

Jyoti Baharani @renalpages.bsky.social · 20/06/2025

🧠 New publication latent TB screening in CKD 📈 TB incidence in UK dialysis patients > some high-burden countries, yet national screening guidance unclear. We call for equitable access 👉 : doi.org/10.1093/ckj/... #Nephrology #TB #CKD #LTBI #PublicHealth #Dialysis #HealthEquity #MigrationHealth

175

Jyoti Baharani @renalpages.bsky.social · 01/03/2025

Wishing all those observing Ramadan a blessed and peaceful month. May this be a time of reflection, gratitude, and spiritual growth. May your fasts be accepted, your prayers answered, and your days filled with Barakah and Noor. Ramadan Mubarak! # #Ramadan #RamadanMubarak #Blessings”

070

Jyoti Baharani @renalpages.bsky.social · 16/02/2025

🚨 New research alert! 🚨 Our latest study, published in BMJ Open, explores gender, race, and ethnicity biases experienced by hospital physicians. We conducted an umbrella review to map the evidence and highlight key gaps. Read more here bmjopen.bmj.com/content/bmjo... #MedTwitter #EquityInMedicine

bmjopen.bmj.com

140

Jyoti Baharani @renalpages.bsky.social · 14/02/2025

#Nephrology Fact for #Valentine’s Day: Dark chocolate 🍫contains oxalates, which can contribute to kidney stones in susceptible individuals. Those with a history of calcium oxalate stones are often advised to moderate their intake of high-oxalate foods, including dark chocolate. 💝🩺

011

Jyoti Baharani @renalpages.bsky.social · 12/02/2025

I met my younger self for coffee today… ☕ I smiled at the eager, determined girl sitting across from me—navigating long shifts, tough decisions, and moments of doubt. Worn out by criticism from folk doubting her abilities …I’d tell her ….

110

Reposted by Jyoti Baharani

Kidney Care UK @kidneycareuk.bsky.social · 08/02/2025

❗DEADLINE Tues 11 Feb. Thank you so much to everyone who has completed our survey so far. However, it's not too late to take part! If you’re over 18, a UK resident and have been diagnosed with chronic kidney disease, we need your input. Link here: surveymonkey.com/r/HCHZYQM

002

Jyoti Baharani @renalpages.bsky.social · 05/02/2025

1/ 📢 New research alert: The creatinine-cystatin C (Cr/CysC) ratio is shown to predict mortality and technique failure in anuric peritoneal dialysis (PD) patients. This marker might improve patient risk stratification. #RenalFailure #DialysisCare #ClinicalResearch

142

Jyoti Baharani @renalpages.bsky.social · 05/02/2025

1/ 🚨 Early integration of palliative care is shown to improve outcomes like symptom management and advance care planning in non-cancer patients with heart failure, liver disease, and more. Mixed results highlight a need for further research. #PalliativeCare #NonCancerCare

170

Jyoti Baharani @renalpages.bsky.social · 05/02/2025

Deeply saddened by this news. My early primary and secondary education in Kenya, like that of many of my peers, was shaped by the #AgaKhan educational institutions. The values, discipline, and knowledge I gained there played a significant role in shaping who I am today. RIP

030

Jyoti Baharani @renalpages.bsky.social · 29/01/2025

Grateful for another year around the sun and a work friends who are more like family #teamrenal

2130

Jyoti Baharani @renalpages.bsky.social · 29/01/2025

Happy lunar new year to all celebrating 🥳

010

Jyoti Baharani @renalpages.bsky.social · 29/01/2025

🚿 New Study Alert: Should Hemodialysis Patients with Catheters Shower? A survey of 304 healthcare providers & 89 patients 74% of patients want to shower 42% are told not to. 53% of providers fear infections 35% of patients would join a study to test safe shower protocols.

220

Jyoti Baharani @renalpages.bsky.social · 25/01/2025

📝 journals.lww.com/jasn/fulltext/9900… This study evaluates pregnancy outcomes in women with #kidney #transplants compared to the general population using registry data from Australia and New Zealand.

100

Jyoti Baharani @renalpages.bsky.social · 25/01/2025

1️⃣ Study Overview “This paper explores the link between acute kidney injury (AKI) and cognitive outcomes (mild cognitive impairment & dementia) using data from the SPRINT trial. It highlights the long-term risks of even mild, reversible AKI. #AKI #DementiaResearch #Nephrology”

100

Jyoti Baharani @renalpages.bsky.social · 24/01/2025

🌍📚 On #WorldEducationDay, let’s talk about how education transforms health. Health literacy the ability to understand and act on health information plays a crucial role in managing CKD ➡️ Early detection of CKD often hinges on awareness of risk factors

121

Jyoti Baharani @renalpages.bsky.social · 14/01/2025

Palliative Care Amid Adversity – Lessons from Lebanon 🌍 In the face of Lebanon’s socio-political and economic challenges, a recent study sheds light on the pressing need for equitable palliative care services in low-income settings.

130

Jyoti Baharani @renalpages.bsky.social · 13/01/2025

🌟 #Dialysis Choices: Insights from Healthcare Professionals in India & the UK 🌟 I’ve had the privilege of conducting two r studies exploring nephrology healthcare workers would choose for themselves if faced with dialysis. Here’s what they reveal:

110

Jyoti Baharani @renalpages.bsky.social · 12/01/2025

BK Polyomavirus-Associated Nephropathy - BKPyVAN is a significant cause of kidney transplant complications. With no standardized treatment protocols, immunosuppression reduction remains the cornerstone of management. #TransplantNephrology #BKPyVAN

150

Jyoti Baharani @renalpages.bsky.social · 10/01/2025

The PDTAP Study on #Haemoglobin Cut-Offs in #Peritoneal #Dialysis The PDTAP study examines Hb thresholds and their impact on outcomes in incident peritoneal PD patients. What Hb levels should clinicians target to minimize risks? #Nephrology #PeritonealDialysis

110

Jyoti Baharani @renalpages.bsky.social · 09/01/2025

#Hyperkalemia in #CKD is a life-threatening condition linked to arrhythmias and mortality. This consensus emphasizes potassium binders as a cornerstone for managing persistent hyperkalemia while preserving the benefits of RAAS inhibitors. #Nephrology

262

Jyoti Baharani @renalpages.bsky.social · 07/01/2025

The Utility of Brief Instruments for Depression Screening in Dialysis Patients 💔 Depression in dialysis patients is prevalent but often underdiagnosed. This article highlights how short tools like BDI-FS and HADS-D could improve mental health screening, improving patient care,

150

Jyoti Baharani @renalpages.bsky.social · 06/01/2025

Motivational Interviewing (MI) is reshaping advance care planning (ACP) A systematic review shows MI empowers older adults to overcome emotional barriers & complete advance directives with confidence. #PalliativeCare spcare.bmj.com/content/bmjspcare/14…

140

Jyoti Baharani @renalpages.bsky.social · 06/01/2025

💡 The Hidden Cost of Healthcare: Electricity for Medical Devices 💡 Did you know that households relying on durable medical equipment (DME) like oxygen concentrators, ventilators, or dialysis machines face significantly higher energy bills?

120

Jyoti Baharani @renalpages.bsky.social · 24/12/2024

What’s #xmas without wonky gingerbread cookies #MerryChristmas all 🎄🎅🏻

020

Jyoti Baharani @renalpages.bsky.social · 24/12/2024

✨ “If Disney Princesses Were Patients” ✨ A feature in this year’s BMJ Christmas Edition explores the hidden health risks of Disney princesses. Beyond unrealistic beauty standards and ideal relationships, what would happen if we examined their lives through the lens of healthcare?

100

Jyoti Baharani @renalpages.bsky.social · 20/12/2024

I share this video once a year - it’s a busy time of the year and sometimes we forget we should be kind to each other….watch and remember to #bekind this holiday season and beyond …https://youtu.be/IQtOgE2s2xI?si=mI5abNL4Xzr6pGFR

000

Jyoti Baharani @renalpages.bsky.social · 19/12/2024

🚨 Reducing CRBSI in Hemodialysis with Lean Six Sigma 🚨 A new study highlights the success of Lean Six Sigma in reducing Catheter-Related Bloodstream Infections (CRBSI) in non-ICU nephrology settings. #Nephrology #PatientSafety #LeanSixSigma #QualityImprovement #CRBSI

152

Jyoti Baharani @renalpages.bsky.social · 17/12/2024

Sometimes - all the work is worth it - forever indebted to some of the great people I’ve had the pleasure to look after - #notcrying #patientcare #CKD 🥺

050

Jyoti Baharani @renalpages.bsky.social · 16/12/2024

7 days before Christmas and 7 trials that have shaped my clinical work - #Nephroadvent #NephroNovena

181

Reposted by Jyoti Baharani

Becky Bonfield @beckybonfield.bsky.social · 13/12/2024

🚨Just published🚨 The National AKI Summit Report is out, addressing persistent challenges in AKI care with system wide recommendations. Read the full report now: bit.ly/4g8nFcj

bit.ly

155

Jyoti Baharani @renalpages.bsky.social · 15/12/2024

Sometimes kids movies have the deepest messages …#ThePolarExpress

010

Jyoti Baharani @renalpages.bsky.social · 15/12/2024

#Avacopan-Induced Liver Injury in #AAV Patients 1/ A recent study in investigates drug-induced liver injury (DILI) linked to avacopan in patients with ANCA-associated vasculitis Results raise concerns about liver safety, especially in Japan. #Rheumatology #AAV #AvacopanSafety

110

Jyoti Baharani @renalpages.bsky.social · 14/12/2024

“Challenges and Outcomes of Long-Term #Tunnelled #Dialysis #Catheter Use: Insights from a Retrospective Study”

100

Jyoti Baharani @renalpages.bsky.social · 14/12/2024

Sodium-glucose cotransporter type 2 inhibitors (#SGLT2i), such as dapagliflozin, have shown significant benefits in reducing cardiovascular deaths and hospitalizations in heart failure patients. However, their real-world application often lags behind clinical trial findings.

100

Jyoti Baharani @renalpages.bsky.social · 13/12/2024

🌟 Long-Term Benefits and Safety of #Statins in Kidney Failure 🌟 A study using target trial emulation has shown that statins can significantly reduce the risk of CVD and all-cause mortality in patients with kidney failure. Importantly, with no increase in major adverse events.

110